FGF-2 and VEGF functionalization of starPEG-heparin hydrogels to modulate biomolecular and physical cues of angiogenesis.

[1]  C. Werner,et al.  Analytical approaches to uptake and release of hydrogel-associated FGF-2 , 2010, Journal of materials science. Materials in medicine.

[2]  C. Werner,et al.  Enzymatically degradable heparin-polyethylene glycol gels with controlled mechanical properties. , 2010, Chemical communications.

[3]  Carsten Werner,et al.  A star-PEG-heparin hydrogel platform to aid cell replacement therapies for neurodegenerative diseases. , 2009, Biomaterials.

[4]  David J. Mooney,et al.  Growth Factors, Matrices, and Forces Combine and Control Stem Cells , 2009, Science.

[5]  Kristi L Kiick,et al.  Production of heparin-containing hydrogels for modulating cell responses. , 2009, Acta biomaterialia.

[6]  Xinqiao Jia,et al.  Hybrid multicomponent hydrogels for tissue engineering. , 2009, Macromolecular bioscience.

[7]  Y. Joung,et al.  Controlled release of heparin-binding growth factors using heparin-containing particulate systems for tissue regeneration , 2008 .

[8]  Smadar Cohen,et al.  The effect of sulfation of alginate hydrogels on the specific binding and controlled release of heparin-binding proteins. , 2008, Biomaterials.

[9]  David J Mooney,et al.  New materials for tissue engineering: towards greater control over the biological response. , 2008, Trends in biotechnology.

[10]  J. Tessmar,et al.  Matrices and scaffolds for protein delivery in tissue engineering. , 2007, Advanced drug delivery reviews.

[11]  J. Tessmar,et al.  Customized PEG-derived copolymers for tissue-engineering applications. , 2007, Macromolecular bioscience.

[12]  D. Nanus,et al.  Neprilysin Inhibits Angiogenesis via Proteolysis of Fibroblast Growth Factor-2* , 2006, Journal of Biological Chemistry.

[13]  A. Hoffman,et al.  PEG-cross-linked heparin is an affinity hydrogel for sustained release of vascular endothelial growth factor , 2006, Journal of biomaterials science. Polymer edition.

[14]  Peter Carmeliet,et al.  Angiogenesis in life, disease and medicine , 2005, Nature.

[15]  Christopher S. Chen,et al.  Engineering biomaterials to control cell function , 2005 .

[16]  Glenn D Prestwich,et al.  Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor. , 2005, Biomaterials.

[17]  K. Anseth,et al.  Heparin functionalized PEG gels that modulate protein adsorption for hMSC adhesion and differentiation. , 2005, Acta biomaterialia.

[18]  M. Luisa Iruela-Arispe,et al.  Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors , 2005, The Journal of cell biology.

[19]  P. Dell’Era,et al.  Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. , 2005, Cytokine & growth factor reviews.

[20]  J. Hubbell,et al.  Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering , 2005, Nature Biotechnology.

[21]  Bart Landuyt,et al.  Vascular Endothelial Growth Factor and Angiogenesis , 2004, Pharmacological Reviews.

[22]  H. Habuchi,et al.  Characterization of Growth Factor-binding Structures in Heparin/Heparan Sulfate Using an Octasaccharide Library* , 2004, Journal of Biological Chemistry.

[23]  A. Mikos,et al.  Angiogenesis with biomaterial-based drug- and cell-delivery systems , 2004, Journal of biomaterials science. Polymer edition.

[24]  A. Panitch,et al.  Physical polymer matrices based on affinity interactions between peptides and polysaccharides. , 2003, Biomacromolecules.

[25]  C. Werner,et al.  Quantitative analysis of immobilized proteins and protein mixtures by amino acid analysis. , 2003, Journal of chromatography. A.

[26]  C. Werner,et al.  Maleic anhydride copolymers--a versatile platform for molecular biosurface engineering. , 2003, Biomacromolecules.

[27]  G. Torri,et al.  Chemical Derivatization as a Strategy to Study Structure-Activity Relationships of Glycosaminoglycans , 2002, Seminars in thrombosis and hemostasis.

[28]  M. Tanihara,et al.  Sustained release of basic fibroblast growth factor and angiogenesis in a novel covalently crosslinked gel of heparin and alginate. , 2001, Journal of biomedical materials research.

[29]  X Huang,et al.  On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[30]  J. Hubbell,et al.  Development of fibrin derivatives for controlled release of heparin-binding growth factors. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[31]  Napoleone Ferrara,et al.  Clinical applications of angiogenic growth factors and their inhibitors , 1999, Nature Medicine.

[32]  M. Ishihara,et al.  Structural features in heparin that interact with VEGF165 and modulate its biological activity. , 1999, Glycobiology.

[33]  A A Poot,et al.  Improved endothelialization of vascular grafts by local release of growth factor from heparinized collagen matrices. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[34]  A. D. de Vos,et al.  Vascular endothelial growth factor: crystal structure and functional mapping of the kinase domain receptor binding site. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Jussi Taipale,et al.  Growth factors in the extracellular matrix , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  Hung V. Nguyen,et al.  The Carboxyl-terminal Domain(111165) of Vascular Endothelial Growth Factor Is Critical for Its Mitogenic Potency (*) , 1996, The Journal of Biological Chemistry.

[37]  D C Rees,et al.  Heparin Structure and Interactions with Basic Fibroblast Growth Factor , 1996, Science.

[38]  S. Brew,et al.  Purification of human plasma fibronectin , 1994 .

[39]  D. Rifkin,et al.  Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. , 1994, The Journal of biological chemistry.

[40]  J. Folkman,et al.  Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[41]  L. Orci,et al.  Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. , 1992, Biochemical and biophysical research communications.

[42]  S. Soker,et al.  The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. , 1992, The Journal of biological chemistry.

[43]  R Langer,et al.  Controlled and modulated release of basic fibroblast growth factor. , 1991, Biomaterials.

[44]  B. Matthews,et al.  Three-dimensional structure of human basic fibroblast growth factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Jeffrey D. Esko,et al.  Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor , 1991, Cell.

[46]  G. Rodgers,et al.  Improved method of human umbilical arterial endothelial cell culture. , 1991, Thrombosis research.

[47]  D E Ingber,et al.  Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix , 1989, The Journal of cell biology.

[48]  D. Rifkin,et al.  Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation , 1988, The Journal of cell biology.

[49]  K H Jones,et al.  An improved method to determine cell viability by simultaneous staining with fluorescein diacetate-propidium iodide. , 1985, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[50]  D. Mooney,et al.  Polymeric systems for bioinspired delivery of angiogenic molecules , 2006 .

[51]  P. Janmey,et al.  Effects of substrate stiffness on cell morphology, cytoskeletal structure, and adhesion. , 2005, Cell motility and the cytoskeleton.

[52]  B. Zetter,et al.  Differential endothelial migration and proliferation to basic fibroblast growth factor and vascular endothelial growth factor. , 1996, Growth factors.

[53]  T. Arakawa,et al.  Stoichiometry of heparin binding to basic fibroblast growth factor. , 1994, Archives of biochemistry and biophysics.